-The Economic Times In a first for the state, newly elected Uttar Pradesh chief minister Akhilesh Yadav has publicly declared his assets worth 4.83 crore, setting the tone for his cabinet colleagues to come out and declare their net worth. Agency reports said that in the 2009 Lok Sabha elections when Akhilesh Yadav filed his nomination papers for Kannauj parliamentary seat, he had declared movable and immovable assets of more than 5.52...

-PTI   Setting a precedent before his cabinet colleagues, Uttar Pradesh Chief Minister Akhilesh Yadav has officially declared his assets and liabilities worth over Rs 4.83 crore.  Akhilesh, 38, who uploaded details of his assets and liabilities on the official website of the state government, is the first Uttar Pradesh Chief Minister to make a public declaration.  In the 2009 Lok Sabha elections when Akhilesh filed his nomination papers for Kannauj parliamentary seat, he...

-Reuters   Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital.  "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...

Compulsory licence can go a long way to ensure access to cheaper drugs In a momentous development, the Indian patent office issued the ever-compulsory licence in a highly contentious pharmaceutical patent case. The decision is a thumping victory for several patients and health activists who have been fighting what can only be labelled as highly inequitable pricing strategies by multinational drug firms for the past several decades. In August 2011, Natco, an...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...